Literature DB >> 7995982

Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses.

X Xu1, E D Kilbourne, H E Hall, N J Cox.   

Abstract

Seven influenza A (H3N2) high-yielding vaccine candidate strains were examined. Antigenic analysis revealed that 5 of the strains could be distinguished antigenically from their corresponding wild type parent viruses. Comparative sequence data for the HA1 domains of the HA (hemagglutinin) genes for these 5 high-yielding viruses and the corresponding wild type parents demonstrated one to three amino acid substitutions within each virus pair, with at least one amino acid change being located in a previously defined antigenic site. Comparison of the HA sequences of the 2 antigenically indistinguishable virus pairs revealed no amino acid differences in 1 and one amino acid change in the other. Examination of 1 additional wild type virus, A/Guangdong/39/89, and its three high-yielding derivatives obtained either by serial egg passage or by reassortment revealed an additive effect of the HA and M genes in creating the high-yielding phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995982     DOI: 10.1093/infdis/170.6.1432

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: evidence for genetic reassortment of the six internal genes.

Authors:  S E Lindstrom; Y Hiromoto; R Nerome; K Omoe; S Sugita; Y Yamazaki; T Takahashi; K Nerome
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

2.  HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains.

Authors:  R Pyhälä; N Ikonen; M Haanpää; L Kinnunen
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.

Authors:  Karen Ivinson; Georgia Deliyannis; Leanne McNabb; Lara Grollo; Brad Gilbertson; David Jackson; Lorena E Brown
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

4.  A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV.

Authors:  Tiffany M Turner; Les P Jones; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

5.  Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs.

Authors:  James Stevens; Li-Mei Chen; Paul J Carney; Rebecca Garten; Angie Foust; Jianhua Le; Barbara A Pokorny; Ramanunninair Manojkumar; Jeanmarie Silverman; Rene Devis; Karen Rhea; Xiyan Xu; Doris J Bucher; James C Paulson; James Paulson; Nancy J Cox; Alexander Klimov; Ruben O Donis
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Pulmonary collectins modulate strain-specific influenza a virus infection and host responses.

Authors:  Samuel Hawgood; Cynthia Brown; Jess Edmondson; Amber Stumbaugh; Lennell Allen; Jon Goerke; Howard Clark; Francis Poulain
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus.

Authors:  Joanna C A Cobbin; Erin E Verity; Brad P Gilbertson; Steven P Rockman; Lorena E Brown
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

8.  Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity.

Authors:  Brad Gilbertson; Wy Ching Ng; Simon Crawford; Jenny L McKimm-Breschkin; Lorena E Brown
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.